Clinical Trial Update: Analyzing IBS to Identify Biomarkers and Microbiome Signatures [NA]

View source ↗

Summary

Mayo Clinic conducts a clinical trial to identify biomarkers and microbiome signatures in diarrhea-predominant irritable bowel syndrome; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Mayo Clinic | Conditions: Diarrhoea Predominant Irritable Bowel Syndrome, IBS | NA | Status: COMPLETED